B
23.40
1.98 (9.24%)
| 前收盘价格 | 21.42 |
| 收盘价格 | 22.30 |
| 成交量 | 1,920,290 |
| 平均成交量 (3个月) | 1,256,214 |
| 市值 | 2,388,321,024 |
| 股市价格/股市净资产 (P/B) | 5.64 |
| 52周波幅 | |
| 利润日期 | 6 May 2025 - 21 May 2025 |
| 稀释每股收益 (EPS TTM) | -9.28 |
| 总债务/股东权益 (D/E MRQ) | 8.64% |
| 流动比率 (MRQ) | 3.49 |
| 营业现金流 (OCF TTM) | -582.45 M |
| 杠杆自由现金流 (LFCF TTM) | -364.16 M |
| 资产报酬率 (ROA TTM) | -96.85% |
| 股东权益报酬率 (ROE TTM) | -198.83% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Biohaven Ltd. | 看跌 | 看跌 |
AIStockmoo 评分
2.5
| 分析师共识 | 3.0 |
| 内部交易活动 | NA |
| 价格波动 | 4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 0.0 |
| 平均 | 2.50 |
|
Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. Its products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Core |
| 内部持股比例 | 11.97% |
| 机构持股比例 | 91.84% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Suvretta Capital Management, Llc | 31 Dec 2024 | 5,620,271 |
| Bellevue Group Ag | 31 Dec 2024 | 2,040,853 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 68.00 (JP Morgan, 190.60%) | 购买 |
| 中 | 62.00 (164.96%) | |
| 低 | 54.00 (HC Wainwright & Co., 130.77%) | 购买 |
| 平均值 | 61.33 (162.09%) | |
| 总计 | 6 购买 | |
| 平均价格@调整类型 | 31.58 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Baird | 28 Apr 2025 | 57.00 (143.59%) | 购买 | 23.40 |
| Morgan Stanley | 07 Mar 2025 | 63.00 (169.23%) | 购买 | 29.86 |
| JP Morgan | 05 Mar 2025 | 68.00 (190.60%) | 购买 | 30.97 |
| HC Wainwright & Co. | 04 Mar 2025 | 54.00 (130.77%) | 购买 | 31.37 |
| RBC Capital | 04 Mar 2025 | 61.00 (160.68%) | 购买 | 31.37 |
| Deutsche Bank | 11 Feb 2025 | 65.00 (177.78%) | 购买 | 42.53 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合